‡a
Author's Galectin-3, GDF-15, and sST2 for the Assessment of Disease Severity and Therapy Response in patients suffering from inoperable Chronic Thromboembolic Pulmonary Hypertension
‡a
galectin3gdf15andsst2fortheassessmentofdiseaseseverityandtherapyresponseinpatientssufferingfrominoperablechronicthromboembolicpulmonaryhypertension
‡A
Galectin-3, GDF-15, and sST2 for the Assessment of Disease Severity and Therapy Response in patients suffering from inoperable Chronic Thromboembolic Pulmonary Hypertension
‡9
1